Trial Profile
A clinical trial of vofatamab monotherapy in non-muscle invasive bladder cancer (NMIBC)
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 09 Dec 2018
Price :
$35
*
At a glance
- Drugs Vofatamab (Primary)
- Indications Bladder cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms FIERCE 23
- 09 Dec 2018 New trial record
- 27 Nov 2018 According to a Rainier Therapeutics media release, this trial is planned to start in 2019.